# Acceptability of a Fixed Combination of Fenofibrate and Metformin

> **NCT00348725** · PHASE3 · COMPLETED · sponsor: **Solvay Pharmaceuticals** · enrollment: 69 (—)

## Conditions studied

- Dyslipidemia/Glucose Metabolism Disorder

## Interventions

- **DRUG:** fenofibrate and metformin fixed combination (drug)

## Key facts

- **NCT ID:** NCT00348725
- **Lead sponsor:** Solvay Pharmaceuticals
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-04
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** 69 (—)
- **Last updated:** 2007-09-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00348725

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00348725, "Acceptability of a Fixed Combination of Fenofibrate and Metformin". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT00348725. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*